Pulmonary Rehabilitation Certificate Course

This presentation will discuss the pathophysiology, diagnosis, treatment strategies, and assessment components of non-COPD chronic pulmonary disease.

At the end of this presentation, the participant will be able to

• Discuss the pathology of non-COPD obstructive lung diseases, restrictive lung diseases and vascular lung disease
• Identify the educational components for patients with non-COPD obstructive lung diseases, restrictive lung diseases, vascular lung disease and post-lung transplant patients
• Discuss exercise prescription for patients with non-COPD obstructive lung diseases, restrictive lung diseases, vascular lung disease and post-lung transplant patients

This video is approximately 58 minutes in length.

Speaker Information

• Brian Carlin MD
• Janie Knipper RN, MA, AE-C, FAACVPR

This presentation will focus on collaborating with patients enrolled in pulmonary rehabilitation to maximize success of the program.

At the end of this presentation, the participant will be able to

• Describe collaborative self-management
• Discuss the utility of using motivational interviewing as a health coaching strategy to guide positive behavior change and successful self-management
• Discuss the importance of self-efficacy in the success of collaborative self-management
• Discuss implementation of individualized collaborative self-management training in the clinical setting

This video is approximately 60 minutes in length.

Speaker Information

• Janie Knipper RN, MA, AE-C
• Charlotte Teneback MD

This presentation is a two-part comprehensive exercise assessment, prescription, and training in pulmonary rehabilitation module.

At the end of this presentation, the participant will be able to

• Describe the purpose and relative importance of exercise testing in pulmonary rehabilitation candidates and participants
• Identify appropriate exercise assessments that provide meaningful information and are recognized as acceptable options and outcomes for pulmonary rehabilitation participants
• Demonstrate knowledge necessary pertaining to your area of clinical specialization in administering tests in accordance with safety and updated guidelines and/or cite resources where specific information pertaining to this area can be found
• Understand the utility of the 6 Minute Walk Test (6MWT) as it relates to pulmonary rehabilitation participants
• List the recommended core components for prescribing exercise
• Utilize information obtained from an exercise test to guide individualized exercise prescription
• Understand guidelines for prescribing exercise for endurance and resistance training for participants in pulmonary rehabilitation with chronic respiratory disease and considerations for flexibility/joint range of motion
• Describe strategies that are recommended for maximizing exercise training benefits in pulmonary rehabilitation patients
• Understand and implement disease specific considerations into pulmonary rehabilitation exercise training programs
• Describe the AACVPR program certification documentation requirements for an individualized treatment plan related to exercise prescription.

The first part of this series is approximately 42 minutes in length and the second part is approximately 1 hour and 39 minutes in length.

Speaker Information

• Kim Eppen PT, PhD
• Chris Garvey FNP, MSN, MPA, MAACVPR

This presentation will discuss malnutrition in the context of pulmonary disease and developing nutrition strategies for patients with pulmonary disease.

At the end of this presentation, the participant will be able to:

• Describe the measurement of malnutrition
• Describe the effects of malnutrition on patients with pulmonary disease
• Develop a nutrition strategy for patients with pulmonary disease

This video is approximately 24 minutes in length.

Speaker Information

• Karen Gregory DNP, RRT, AE-C, FAARC

This presentation will focus on outcome measures to identify the success of pulmonary rehabilitation programs.

At the end of this presentation, the participant will be able to

• Describe the foundational concepts of outcomes in healthcare
• Identify the evidence-based outcomes for pulmonary rehabilitation
• Identify valid and reliable instruments to measure pulmonary rehabilitation outcomes
• Discuss the process considerations when measuring outcomes in pulmonary rehabilitation

This video is approximately 38 minutes in length.

Speaker Information

• Gerene Bauldoff PhD RN, FAACVPR
• Eileen Collins PhD, RN, FAACVPR

This presentation will discuss the pathophysiology, diagnosis, treatment strategies, and assessment components of COPD.

At the end of this presentation, the participant will be able to:

• Explain the pathophysiology of COPD
• Describe the methods of COPD diagnosis
• Identify treatment strategies for COPD
• Describe components of assessment for a patient with COPD

This video is approximately 49 minutes in length.

Speaker Information

• Richard Casaburi MD, MEng, PhD

This presentation will discuss currently available pulmonary medications and their indications, delivery methods, and medication interaction.

At the end of this presentation, the participant will be able to:

• List currently available pulmonary medications
• Describe indications for various pulmonary medications based on scientific evidence and use in specific disease processes
• Determine appropriate delivery method for inhaled medications based on patient cognition, physical ability, and preference

This video is approximately 1 hour and 23 minutes in length.

Speaker Information

• Timothy Myers MBA, RRT, RRT-NPS, FAARC

This presentation will focus on the need for psychosocial assessment and relevant interventions for patients who are enrolled in pulmonary rehabilitation programs.

At the end of this presentation, the participant will be able to

• Identify components of psychosocial assessment including psychosocial screeners
• Discuss common signs and symptoms of depression and anxiety including some tools that can be applicable in the pulmonary rehabilitation program
• Discuss basic tenets of Motivational
• Interviewing to enhance adherence in pulmonary rehabilitation

This video is approximately 1 hour and 3 minutes in length.

Speaker Information

• Maria Buckley PhD, FAACVPR
• Kent Eichenauer PsyD, FAACVPR

This presentation will define pulmonary rehabilitation and describe the essential components of a comprehensive pulmonary rehabilitation program.

At the end of this presentation, the participant will be able to

• Define pulmonary rehabilitation
• Describe the essential components of a comprehensive pulmonary rehabilitation program
• Explain the benefits of pulmonary rehabilitation

This video is approximately 1 hour and 13 minutes in length.

Speaker Information

• Trina Limberg BS, RRT, FAARC, MAACVPR

This presentation will describe the physiologic benefit of supplemental oxygen while also assisting the health care professional in differentiating between home systems and determining the appropriate delivery system to meet patient need.

At the end of this presentation, the participant will be able to:

• Describe the physiological benefit of supplemental oxygen
• Differentiate between various home oxygen delivery systems
• Determine appropriate delivery system to meet patient need

This video is approximately 37 minutes in length.

Speaker Information

• Curt Merriman BA, RRT, CPFT

This presentation will assist the participant in differentiating the various types of pulmonary function tests and their use among the disease processes discussed in the course as well as identifying disease severity based on pulmonary function test results.

At the end of this presentation, the participant will be able to:

• Define three types of pulmonary function tests
• Review reference equations/predicted values/lower limits of normal
• Describe quality testing criteria
• Describe and review lung volumes and capacities
• Identify specific pulmonary abnormalities with pulmonary function tests
• Identify disease severity with pulmonary function tests

This video is approximately 47 minutes in length.

Speaker Information

• Curt Merriman BA, RRT, CPFT

This presentation will define pulmonary rehabilitation and describe the essential components of a comprehensive pulmonary rehabilitation program.

At the end of this presentation, the participant will be able to:

• Define pulmonary rehabilitation
• Describe the essential components of a comprehensive pulmonary rehabilitation program
• Explain the benefits of pulmonary rehabilitation

This video is approximately 1 hour and 13 minutes in length.

This presentation is sponsored by the American Association of Cardiovascular and Pulmonary Rehabilitation.

Speaker Information

• Trina Limberg BS, RRT, FAARC, MAACVPRT

This presentation will explain the scientific factors supporting tobacco cessation, general approaches to smoking cessation, and pharmacologic agents in tobacco cessation programs.

At the end of this presentation, the participant will be able to:

• Explain the scientific factors supporting tobacco cessation
• Identify general approaches to smoking cessation
• Explain the pharmacologic agents employed in a tobacco cessation program.

The video for part 1 is approximately 23 minutes in length.

Speaker Information

• Sarah Varekojis PhD, RRT, FAARC

This video introduces the learner to the AARC and AACVPR Pulmonary Rehabiltiation Certification course.

This video is approximately 2 minutes in length.

Speaker Information

Disclosures:

There is no conflict of interest for anyone with the ability to control content for this activity except for:

• Brian Carlin MD: The presenter discloses relationships with Sunovion, Monaghan, GlaxoSmithKline, Nonin, and Philips Respironics, Inc.
• Richard Casaburi MD, MEng, PhD: The presenter discloses relationships with Boehringer Ingelheim, Novartis, GlaxoSmithKline, and Astra Zeneca.
• Kent Eichenauer PsyD, FAACVPR: This presenter discloses that he is a co-author of the psychological screener, the Psychosocial Risk Factor Survey.
• Kim Eppen PT, PhD: This presenter discloses a relationship with Relias Learning.
• Chris Garvey FNP, MSN, MPA, MAACVPR: This presenter discloses a relationship with Boehringer Ingelheim.